/Investor DB

Israel Biotech Fund — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Vensicavensica.cominNov 2021✓ verified

Vensica is a clinical-stage medical company developing ViXe, a needle-free treatment for overactive bladder that combines the neurotoxin Xeomin with Vibe, an ultrasound-based drug delivery device that microinjects medication into the bladder wall.

BiotechHealthtechMedical Devices

Avner Geva(CEO, Co-founder)inAvi Eftel(CTO, Co-founder)inRoger R. Dmochowski(CMO)Ken Berlin(Executive Chairman)in

Co-investorsTrendlines Group

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.